Rosamonde E. Banks

University of Leeds — United Kingdom

Medicine · Health Sciences

73h-index29.1kcitations380works5.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(99), Cancer Genomics and Diagnostics(76), Advanced Proteomics Techniques and Applications(54), Renal and related cancers(38), Epigenetics and DNA Methylation(34)

Publications339 total

Supplementary Methods S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Table S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S1 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Tables S3-S13 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Figure S3 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Supplementary Table S2 from Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma
2025Open Access
Biomarker Prediction of Delayed Graft Function and Prognosis Post–Kidney Transplantation
Kidney International Reports·2025Open Access
Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes
International Journal of Epidemiology·2025
#2236 Creatinine muscle index (CMI) is independently associated with markers of Sarcopenia and mortality in chronic kidney disease
Nephrology Dialysis Transplantation·2025
Biomarkers of Kidney Failure and All-Cause Mortality in CKD
Journal of the American Society of Nephrology·2025· 5 cited
Comparing Cystatin C Estimated GFR With Creatinine Estimated GFR in Acute Kidney Injury Recovery
Kidney International Reports·2025· 1 citedOpen Access
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study
British Journal of Cancer·2025
Personalized Care in CKD: Moving Beyond Traditional Biomarkers
˜The œNephron journals/Nephron journals·2025· 6 citedOpen Access
Mechanistic insights from a pilot exploratory study of the dynamic proteomic changes during plasma exchange in patients with acute liver failure
Transfusion and Apheresis Science·2024
The Impact of Primary Renal Diagnosis on Prognosis and the Varying Predictive Power of Albuminuria in the NURTuRE-CKD Study
American Journal of Nephrology·2024· 2 citedOpen Access
Long-read RNA sequencing of archival tissues reveals novel genes and transcripts associated with clear cell renal cell carcinoma recurrence and immune evasion
Genome Research·2024· 3 citedOpen Access
Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma
The American Journal of Human Genetics·2024· 9 citedOpen Access
Geographic variation of mutagenic exposures in kidney cancer genomes
Nature·2024· 60 citedOpen Access
#2755 NURTuRE-CKD: outcomes by primary renal diagnosis
Nephrology Dialysis Transplantation·2024Open Access
page 1 of 17Next →

Frequent Co-authors

Peter J. Selby(26), Patricia Harnden(11), Peter J. Bailey(7), Malik Alawi(6), Rachel A. Craven(6), Ghislaine Scélo(6), Eamonn R. Maher(5), Egor Prokhortchouk(5), Давид Заридзе(5), K. G. Skryabin(5), Lauri A. Aaltonen(4), David J. Adams(4), Keun Soo Ahn(4), Kadir C. Akdemir(4), Hikmat Al‐Ahmadie(4), Sultan T. Al‐Sedairy(4), Fátima Al‐Shahrour(4), Monique Albert(4), Ludmil B. Alexandrov(4), Adrian Ally(4)